Freedman, S. ., Hercinovic, A. ., Wallace, D. K., Kraker, R. ., Li, Z. ., Bhatt, A. ., … Good, W. V. (2022). Low- and Very Low-Dose Bevacizumab for Retinopathy of Prematurity: Reactivations, Additional Treatments, and 12-Month Outcomes. Ophthalmology, 129(10), 1120-1128. 10.1016/j.ophtha.2022.05.019 (Original work published 2022)